Soluble P-selectin predicts lower extremity peripheral artery disease incidence and change in the ankle brachial index: The Multi-Ethnic Study of Atherosclerosis (MESA)

Christina L. Wassel, Cecilia Berardi, James S. Pankow, Nicholas Larson, Paul A. Decker, Naomi Q. Hanson, Michael Y. Tsai, Michael H. Criqui, Matthew A. Allison, Suzette J Bielinski

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: To determine the association of circulating P-selectin with prevalent and incident peripheral artery disease (PAD), the ankle brachial index (ABI), and change in the ABI. Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) is a prospective population-based cohort study including 6814 European descent, African American, Hispanic and Chinese men and women aged 45-84 at baseline. Four clinical exams took place after the baseline exam. After excluding those with ABI>1.4, prevalent and incident PAD were defined as an ABI≤0.90. ABI progression was defined as progression from a normal ABI (0.91-1.4) to abnormal (≤0.90 or >1.4) at a later exam. Results: In adjusted models, each SD (13ng/mL) higher P-selectin was significantly associated with 0.007 lower ABI (95% CI ((-0.011,-0.004)), p<0.001), and an average change in the ABI of-0.006 ((-0.010,-0.003, p<0.001). P-selectin was significantly associated with a 1.17-fold greater odds of prevalent PAD ((1.02, 1.33), p=0.03), and a 30% greater risk of incident PAD ((1.11, 1.53), p=0.001), as well as progression from a normal ABI to an ABI≤ 0.90 (p=0.003), but not to an ABI>1.4 (p=0.96). Addition of P-selectin to models containing traditional PAD risk factors and markers of inflammation/coagulation significantly improved the net reclassification for ABI progression (p=0.03), but was only marginally significant for incident PAD (p=0.06). Conclusions: P-selectin is significantly associated with the development of PAD. However, further research is needed in population-based studies to confirm prospective associations of P-selectin with incident PAD and change in the ABI, as well as its potential predictive ability.

Original languageEnglish (US)
Pages (from-to)405-411
Number of pages7
JournalAtherosclerosis
Volume239
Issue number2
DOIs
StatePublished - Apr 1 2015

Fingerprint

Ankle Brachial Index
P-Selectin
Peripheral Arterial Disease
Lower Extremity
Atherosclerosis
Incidence
Hispanic Americans
African Americans
Population
Cohort Studies
Inflammation

Keywords

  • Ankle brachial index
  • Incidence
  • Net reclassification improvement
  • P-selectin
  • Peripheral artery disease
  • Prediction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Soluble P-selectin predicts lower extremity peripheral artery disease incidence and change in the ankle brachial index : The Multi-Ethnic Study of Atherosclerosis (MESA). / Wassel, Christina L.; Berardi, Cecilia; Pankow, James S.; Larson, Nicholas; Decker, Paul A.; Hanson, Naomi Q.; Tsai, Michael Y.; Criqui, Michael H.; Allison, Matthew A.; Bielinski, Suzette J.

In: Atherosclerosis, Vol. 239, No. 2, 01.04.2015, p. 405-411.

Research output: Contribution to journalArticle

Wassel, Christina L. ; Berardi, Cecilia ; Pankow, James S. ; Larson, Nicholas ; Decker, Paul A. ; Hanson, Naomi Q. ; Tsai, Michael Y. ; Criqui, Michael H. ; Allison, Matthew A. ; Bielinski, Suzette J. / Soluble P-selectin predicts lower extremity peripheral artery disease incidence and change in the ankle brachial index : The Multi-Ethnic Study of Atherosclerosis (MESA). In: Atherosclerosis. 2015 ; Vol. 239, No. 2. pp. 405-411.
@article{3c56cfe331524707a7583a6d0264f293,
title = "Soluble P-selectin predicts lower extremity peripheral artery disease incidence and change in the ankle brachial index: The Multi-Ethnic Study of Atherosclerosis (MESA)",
abstract = "Objective: To determine the association of circulating P-selectin with prevalent and incident peripheral artery disease (PAD), the ankle brachial index (ABI), and change in the ABI. Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) is a prospective population-based cohort study including 6814 European descent, African American, Hispanic and Chinese men and women aged 45-84 at baseline. Four clinical exams took place after the baseline exam. After excluding those with ABI>1.4, prevalent and incident PAD were defined as an ABI≤0.90. ABI progression was defined as progression from a normal ABI (0.91-1.4) to abnormal (≤0.90 or >1.4) at a later exam. Results: In adjusted models, each SD (13ng/mL) higher P-selectin was significantly associated with 0.007 lower ABI (95{\%} CI ((-0.011,-0.004)), p<0.001), and an average change in the ABI of-0.006 ((-0.010,-0.003, p<0.001). P-selectin was significantly associated with a 1.17-fold greater odds of prevalent PAD ((1.02, 1.33), p=0.03), and a 30{\%} greater risk of incident PAD ((1.11, 1.53), p=0.001), as well as progression from a normal ABI to an ABI≤ 0.90 (p=0.003), but not to an ABI>1.4 (p=0.96). Addition of P-selectin to models containing traditional PAD risk factors and markers of inflammation/coagulation significantly improved the net reclassification for ABI progression (p=0.03), but was only marginally significant for incident PAD (p=0.06). Conclusions: P-selectin is significantly associated with the development of PAD. However, further research is needed in population-based studies to confirm prospective associations of P-selectin with incident PAD and change in the ABI, as well as its potential predictive ability.",
keywords = "Ankle brachial index, Incidence, Net reclassification improvement, P-selectin, Peripheral artery disease, Prediction",
author = "Wassel, {Christina L.} and Cecilia Berardi and Pankow, {James S.} and Nicholas Larson and Decker, {Paul A.} and Hanson, {Naomi Q.} and Tsai, {Michael Y.} and Criqui, {Michael H.} and Allison, {Matthew A.} and Bielinski, {Suzette J}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.atherosclerosis.2015.01.022",
language = "English (US)",
volume = "239",
pages = "405--411",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Soluble P-selectin predicts lower extremity peripheral artery disease incidence and change in the ankle brachial index

T2 - The Multi-Ethnic Study of Atherosclerosis (MESA)

AU - Wassel, Christina L.

AU - Berardi, Cecilia

AU - Pankow, James S.

AU - Larson, Nicholas

AU - Decker, Paul A.

AU - Hanson, Naomi Q.

AU - Tsai, Michael Y.

AU - Criqui, Michael H.

AU - Allison, Matthew A.

AU - Bielinski, Suzette J

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Objective: To determine the association of circulating P-selectin with prevalent and incident peripheral artery disease (PAD), the ankle brachial index (ABI), and change in the ABI. Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) is a prospective population-based cohort study including 6814 European descent, African American, Hispanic and Chinese men and women aged 45-84 at baseline. Four clinical exams took place after the baseline exam. After excluding those with ABI>1.4, prevalent and incident PAD were defined as an ABI≤0.90. ABI progression was defined as progression from a normal ABI (0.91-1.4) to abnormal (≤0.90 or >1.4) at a later exam. Results: In adjusted models, each SD (13ng/mL) higher P-selectin was significantly associated with 0.007 lower ABI (95% CI ((-0.011,-0.004)), p<0.001), and an average change in the ABI of-0.006 ((-0.010,-0.003, p<0.001). P-selectin was significantly associated with a 1.17-fold greater odds of prevalent PAD ((1.02, 1.33), p=0.03), and a 30% greater risk of incident PAD ((1.11, 1.53), p=0.001), as well as progression from a normal ABI to an ABI≤ 0.90 (p=0.003), but not to an ABI>1.4 (p=0.96). Addition of P-selectin to models containing traditional PAD risk factors and markers of inflammation/coagulation significantly improved the net reclassification for ABI progression (p=0.03), but was only marginally significant for incident PAD (p=0.06). Conclusions: P-selectin is significantly associated with the development of PAD. However, further research is needed in population-based studies to confirm prospective associations of P-selectin with incident PAD and change in the ABI, as well as its potential predictive ability.

AB - Objective: To determine the association of circulating P-selectin with prevalent and incident peripheral artery disease (PAD), the ankle brachial index (ABI), and change in the ABI. Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) is a prospective population-based cohort study including 6814 European descent, African American, Hispanic and Chinese men and women aged 45-84 at baseline. Four clinical exams took place after the baseline exam. After excluding those with ABI>1.4, prevalent and incident PAD were defined as an ABI≤0.90. ABI progression was defined as progression from a normal ABI (0.91-1.4) to abnormal (≤0.90 or >1.4) at a later exam. Results: In adjusted models, each SD (13ng/mL) higher P-selectin was significantly associated with 0.007 lower ABI (95% CI ((-0.011,-0.004)), p<0.001), and an average change in the ABI of-0.006 ((-0.010,-0.003, p<0.001). P-selectin was significantly associated with a 1.17-fold greater odds of prevalent PAD ((1.02, 1.33), p=0.03), and a 30% greater risk of incident PAD ((1.11, 1.53), p=0.001), as well as progression from a normal ABI to an ABI≤ 0.90 (p=0.003), but not to an ABI>1.4 (p=0.96). Addition of P-selectin to models containing traditional PAD risk factors and markers of inflammation/coagulation significantly improved the net reclassification for ABI progression (p=0.03), but was only marginally significant for incident PAD (p=0.06). Conclusions: P-selectin is significantly associated with the development of PAD. However, further research is needed in population-based studies to confirm prospective associations of P-selectin with incident PAD and change in the ABI, as well as its potential predictive ability.

KW - Ankle brachial index

KW - Incidence

KW - Net reclassification improvement

KW - P-selectin

KW - Peripheral artery disease

KW - Prediction

UR - http://www.scopus.com/inward/record.url?scp=84922815655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922815655&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2015.01.022

DO - 10.1016/j.atherosclerosis.2015.01.022

M3 - Article

C2 - 25682040

AN - SCOPUS:84922815655

VL - 239

SP - 405

EP - 411

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -